IDEXX-Animal Health Firm Idexx's Robust Business Model Bolsters Position Despite Slower Growth, Says Analyst

Tuesday, Idexx Laboratories Inc IDXX reported second-quarter adjusted EPS of $3.02, up 15% year-overyear, beating the consensus of$ 2.88. The company reported sales of $1 billion, an increase of 6% as reported and 7% organically, almost in line with the consensus of$ 1.01 billion. The revenue growth was driven by Companion Animal Group growth of 6% as reported and 7% organic and Water revenue growth of 9% as reported and 10% organic. Related: Aging Pet Population Is 'Solid Longer-Term Tailwind' For Idexx La ...